Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does GABAPENTIN Cause Musculoskeletal stiffness? 581 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 581 reports of Musculoskeletal stiffness have been filed in association with GABAPENTIN (Gabapentin). This represents 0.8% of all adverse event reports for GABAPENTIN.

581
Reports of Musculoskeletal stiffness with GABAPENTIN
0.8%
of all GABAPENTIN reports
63
Deaths
228
Hospitalizations

How Dangerous Is Musculoskeletal stiffness From GABAPENTIN?

Of the 581 reports, 63 (10.8%) resulted in death, 228 (39.2%) required hospitalization, and 60 (10.3%) were considered life-threatening.

Is Musculoskeletal stiffness Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for GABAPENTIN. However, 581 reports have been filed with the FAERS database.

What Other Side Effects Does GABAPENTIN Cause?

Drug ineffective (10,914) Drug hypersensitivity (6,833) Off label use (6,729) Drug ineffective for unapproved indication (5,231) Product use in unapproved indication (4,919) Toxicity to various agents (4,839) Completed suicide (4,111) Dizziness (4,107) Somnolence (3,798) Fatigue (3,791)

What Other Drugs Cause Musculoskeletal stiffness?

ADALIMUMAB (10,762) METHOTREXATE (9,903) ETANERCEPT (9,744) TOFACITINIB (7,354) TOCILIZUMAB (6,346) RITUXIMAB (6,058) LEFLUNOMIDE (6,031) ABATACEPT (5,926) SECUKINUMAB (5,655) HYDROXYCHLOROQUINE (5,271)

Which GABAPENTIN Alternatives Have Lower Musculoskeletal stiffness Risk?

GABAPENTIN vs GABAPENTIN ENACARBIL GABAPENTIN vs GADAVIST GABAPENTIN vs GADOBENATE DIMEGLUMINE GABAPENTIN vs GADOBUTROL GABAPENTIN vs GADODIAMIDE

Related Pages

GABAPENTIN Full Profile All Musculoskeletal stiffness Reports All Drugs Causing Musculoskeletal stiffness GABAPENTIN Demographics